Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Study shows how mesenchymal stromal cells regulate factors driving inflammation in COPD patients

A new phase I clinical study shows, for the first time, how treatment with a type of stem cell called mesenchymal stromal cells is able to regulate important factors driving inflammation in patients with chronic obstructive pulmonary disease (COPD) for a period for time.

18 Aug 2021

Wildfire smoke affects 3 million asthmatics and more than half of the U.S. states, research reveals

An estimated 3 million asthmatics and over half of the states in the United States are being affected by particulates that are blowing over them from fires in Canada and the western U.S., according to new research at The University of Alabama in Huntsville, a part of the University of Alabama System.

16 Aug 2021

Apple aims to push more patient data to doctors. But who can gauge its impact on health?

Soon, Apple announced recently, it will enable doctors to monitor health data from their patients' phones and watches between visits, part of the push into health care that Tim Cook, Apple's CEO, has declared will constitute the company's greatest contribution to mankind.

12 Aug 2021

Researchers create a computational model to evaluate drug delivery through inhalers

Increased air pollution in recent years has not only contributed to deteriorating environmental conditions in cities across the globe.

10 Aug 2021

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

A recent study in Colorado used real-world data to evaluate if individuals with chronic conditions have reduced antibody response to COVID-19 mRNA vaccines. The study investigated whether some medical conditions may impact antibody response to the mRNA vaccines.

9 Aug 2021

Flu vaccine may provide vital protection against COVID-19, study shows

In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.

4 Aug 2021

Economic mobility associated with racial mortality gaps in the United States

A new study suggests structural racism measured by the racial economic mobility gap between Black and White persons with a similar parental income (as an indicator of similar childhood socioeconomic status) is strongly associated with Black-White disparities in mortality in the United States, both in a recent birth cohort and in all ages combined.

4 Aug 2021

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Scientists at Children's Hospital of Philadelphia have identified two proteins that could be used for a potential vaccine against nontypeable Haemophilus influenzae (NTHi).

2 Aug 2021

Scientists uncover genetics involved in COVID-19 induced respiratory failure

A new genetic study from an international team of scientists has uncovered genes involved in severe coronavirus disease 2019 (COVID-19) illness.

27 Jul 2021

Budesonide’s antiviral effect against SARS-CoV-2

A new study examines the in vitro antiviral effect of pure budesonide and Pulmicort® against the SARS-CoV-2 WT and two VoCs.

26 Jul 2021

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Researchers at Weill Cornell Medicine and NewYork-Presbyterian in New York have discovered that injecting mice with pulmonary endothelial cells-the cells that line the walls of blood vessels in the lung-can reverse the symptoms of emphysema.

21 Jul 2021

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It therefore remains unclear whether this form of treatment has advantages over long-term oxygen therapy (LTOT) or non-invasive ventilation (NIV).

20 Jul 2021

Adults with ADHD at higher risk of many physical conditions, finds study

Adults with ADHD are at higher risk of a wide range of physical conditions, including nervous system, respiratory, musculoskeletal, and metabolic diseases, according to a large register-based study from Karolinska Institutet in Sweden published in The Lancet Psychiatry.

7 Jul 2021

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.

6 Jul 2021

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Researchers at the Weill Cornell Medical College aimed to determine the role of overcrowded households as a risk factor for COVID-19. The study's objective, which appeared in the medRxiv* pre-print server, was to examine the link between overcrowded and multigenerational households and COVID-19 in New York City.

25 Jun 2021

Inhibiting necroptosis could be a novel approach for treating COPD

Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease, an inflammatory lung condition, also known as emphysema, that makes it difficult to breathe.

17 Jun 2021

Chronic fatigue a significant challenge for most long COVID patients

Researchers in Canada have conducted a study suggesting that the majority of patients living with long COVID (coronavirus disease) following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience chronic fatigue that is at least as severe as that seen in several other clinical conditions.

15 Jun 2021

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

Researchers at the University of Maryland School of Medicine analyzed data at the 13-hospital University of Maryland Medical System and found public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: Hospital admissions for chronic obstructive pulmonary disease (COPD) were reduced by 53 percent, according to a new study accepted for publication by a peer-reviewed medical journal and currently available at the online journal medRxiv.

14 Jun 2021

Lung protein hyperconcentration may be a key factor in predicting COPD risks

Airway mucus consists of various proteins such as long mucins MUC5AC and MUC5B, both of which contribute greatly to the proper gel-like consistency of this most essential bodily fluid.

3 Jun 2021

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic.

2 Jun 2021

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Study shows how mesenchymal stromal cells regulate factors driving inflammation in COPD patients

Wildfire smoke affects 3 million asthmatics and more than half of the U.S. states, research reveals

Apple aims to push more patient data to doctors. But who can gauge its impact on health?

Researchers create a computational model to evaluate drug delivery through inhalers

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

Flu vaccine may provide vital protection against COVID-19, study shows

Economic mobility associated with racial mortality gaps in the United States

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Scientists uncover genetics involved in COVID-19 induced respiratory failure

Budesonide’s antiviral effect against SARS-CoV-2

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

Adults with ADHD at higher risk of many physical conditions, finds study

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Inhibiting necroptosis could be a novel approach for treating COPD

Chronic fatigue a significant challenge for most long COVID patients

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

Lung protein hyperconcentration may be a key factor in predicting COPD risks

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in